DK487287D0 - Antigestagener til haemning af den uterine prostagladinsyntese - Google Patents

Antigestagener til haemning af den uterine prostagladinsyntese

Info

Publication number
DK487287D0
DK487287D0 DK487287A DK487287A DK487287D0 DK 487287 D0 DK487287 D0 DK 487287D0 DK 487287 A DK487287 A DK 487287A DK 487287 A DK487287 A DK 487287A DK 487287 D0 DK487287 D0 DK 487287D0
Authority
DK
Denmark
Prior art keywords
synthesis
prostaglad
inhibit uterine
agents
stage
Prior art date
Application number
DK487287A
Other languages
English (en)
Other versions
DK169162B1 (da
DK487287A (da
Inventor
Walter Elger
Krzysztof Chwalisz
Sybille Beier
Marianne Faehnrich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK487287D0 publication Critical patent/DK487287D0/da
Publication of DK487287A publication Critical patent/DK487287A/da
Application granted granted Critical
Publication of DK169162B1 publication Critical patent/DK169162B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK487287A 1986-09-26 1987-09-16 Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose DK169162B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3633244 1986-09-26
DE19863633244 DE3633244A1 (de) 1986-09-26 1986-09-26 Antigestagene zur hemmung der uterinen prostaglandinsynthese

Publications (3)

Publication Number Publication Date
DK487287D0 true DK487287D0 (da) 1987-09-16
DK487287A DK487287A (da) 1988-03-27
DK169162B1 DK169162B1 (da) 1994-09-05

Family

ID=6310705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK487287A DK169162B1 (da) 1986-09-26 1987-09-16 Anvendelse af antigestagener til fremstilling af lægemidler til terapi og profylakse af dysmenoréisk besvær samt til behandling af forstyrrelser og besvær fremkaldt af endometriose

Country Status (12)

Country Link
US (1) US5744464A (da)
EP (1) EP0266303B1 (da)
JP (1) JP2582088B2 (da)
AT (1) ATE78690T1 (da)
AU (1) AU605177B2 (da)
DE (2) DE3633244A1 (da)
DK (1) DK169162B1 (da)
ES (1) ES2051766T3 (da)
GR (1) GR3005467T3 (da)
IE (1) IE66196B1 (da)
IL (1) IL83967A (da)
ZA (1) ZA877247B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
FR2651435A1 (fr) * 1989-09-07 1991-03-08 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE19652408C2 (de) * 1996-12-06 2002-04-18 Schering Ag Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
CO5200772A1 (es) 1999-08-31 2002-09-27 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) para el trataiento y la prevencion de transtornos ginecolo- gicos benignos hormona-dependientes
US20100249125A1 (en) * 2009-03-31 2010-09-30 The Texas A&M University System Inhibition of prostglandin e2 receptors for the treatment of endometriosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077437A (en) * 1957-07-29 1963-02-12 George P Heckel Pregnanediol for treatment of premenstrual syndrome
US3666858A (en) * 1967-06-29 1972-05-30 Gordon Alan Hughes Utilization of gon-4-ene therapy in treatment of females and in growth stimulation
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
GR3005467T3 (da) 1993-05-24
JP2582088B2 (ja) 1997-02-19
EP0266303A3 (en) 1989-12-20
DE3633244A1 (de) 1988-03-31
ZA877247B (en) 1988-03-28
IE872578L (en) 1988-03-26
IE66196B1 (en) 1995-12-13
IL83967A (en) 1992-11-15
DK169162B1 (da) 1994-09-05
JPS63101326A (ja) 1988-05-06
AU605177B2 (en) 1991-01-10
DK487287A (da) 1988-03-27
ES2051766T3 (es) 1994-07-01
IL83967A0 (en) 1988-02-29
US5744464A (en) 1998-04-28
DE3780757D1 (de) 1992-09-03
AU7895087A (en) 1988-03-31
EP0266303B1 (de) 1992-07-29
EP0266303A2 (de) 1988-05-04
ATE78690T1 (de) 1992-08-15

Similar Documents

Publication Publication Date Title
DE3689304D1 (de) Synthese von Verbindungen vom Podophylotoxintyp.
DE3772176D1 (de) Synthese von aromatischen bis(etherphthalimid)-verbindungen.
FI891245A0 (fi) Starka soetningsmedel.
FR2600055B1 (fr) Aluminates mixtes de lanthanide-magnesium, lasers utilisant des monocristaux de ces aluminates
DK487287D0 (da) Antigestagener til haemning af den uterine prostagladinsyntese
ES2025154B3 (es) Sintesis del amoniaco.
BG43867A3 (en) Method for preparing of 6- alpha- methylcorticoids
SE8103580L (sv) N?726-substituerade adenosiner
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
BE829999A (fr) Procede de synthese de l'ether-oxyde de bis (2-n,n-dimethylam ino)ethyle)
DE3482556D1 (de) Synthese von silicophosphoaluminaten.
FR2428045A1 (fr) Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs
IT8622467A0 (it) Procedimento per la sintesi di perfluoroalcadieni.
FR2609463B1 (fr) Synthese des perfluoroalkyl-2 ethanethiols
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
FR2603051B1 (fr) Aluminates mixtes de lanthane-magnesium, lasers utilisant des monocristaux de ces aluminates
ES510546A0 (es) "procedimiento de preparar derivados de n-(n-metil-rn(n-aminosulfenil disubstituido)carbamoil)oxi)tioacetamidato de s-metilo".
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DK693588A (da) Storskala syntese af diazamonocykliske forbindelser
DK157779A (da) Fremgangsmaade til omlejring af 10,11-epoxy-10,11-dihydro-5-dibenz(b,f) azepin-5-carboxamid til 10--oxo-10,11dihydro-5h-dibenz (b,f) azepin-5-carboxamid
NO882505D0 (no) Syntese av n-epoksypropyllaktamer.
IT1077051B (it) Procedimento per produrre il miscuglio contenente la 4-(4'-metil-4'-idrossiamil)-delta 3-cicloesenecarbossaldeide e il prodotto con essa ottenuto
TR24090A (tr) Agiz ici dis taslarini oenleyen bilesimler
DE3765295D1 (de) Synthese von hochreinem 5-chlorisophthaloylchlorid.
SU1019825A1 (ru) 2,6-дифенил-4-фосфонтетрагидротиопиранол-4 в качестве катализатора синтеза полиимидов

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK